Platelet Adhesiveness and Cerebral Vascular Disease Revisited

  • E. J. Acheson
Conference paper


In the western world cerebral vascular disease remains a major cause of morbidity and mortality and the pathogenesis has been the subject of much study and discussion in recent years.


Neurol Dipyridamole 


  1. Acheson, J.: Factors affecting the natural history of “Focal cerebral vascular disease”. Quart. J. Med. 40, 25–46 (1971)PubMedGoogle Scholar
  2. Acheson, J., Danta, G., Hutchinson, E.C.: Controlled trial of dipyridamole in cerebral vascular disease. Brit. med. J. 1, 614–615 (1969)PubMedCrossRefGoogle Scholar
  3. Acheson, J., Danta, G., Hutchinson, E.C.: Platelet adhesiveness in patients with cerebral vascular disease. Atherosclerosis 15, 123–127 (1972)PubMedCrossRefGoogle Scholar
  4. Acheson, J., Hutchinson, E.G.: The natural history of “Focal cerebral vascular disease”. Quart. J. Med. 40, 15–23 (1971)PubMedGoogle Scholar
  5. Danta, G.: Platelet adhesiveness in cerebral vascular disease. Atherosclerosis 11, 223–233 (1970)PubMedCrossRefGoogle Scholar
  6. Hutchinson, E.G., Acheson, J.: Natural history of cerebral ischaemia. London: Saunders (in press)Google Scholar
  7. Millar, J.H.D., Dalby, A.M.: Platelet stickiness in cerebrovascular disease. In: Proceedings of the 8th Int. Congr. Neurol. Vienna, Vol. 4, 1:483–487 (1965)Google Scholar
  8. Nelson, E., Sunaga, T., Shimamoto, T.: Microvasculature in focal cerebral ischaemia and infarction. In: Cerebral Vascular Diseases. 8th Princeton Conference. McDowell, F.H., Brennan, R.W. (eds.). New York: Grune and Stratton 1973Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1977

Authors and Affiliations

  • E. J. Acheson

There are no affiliations available

Personalised recommendations